Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

Todd Neale

July 31, 2025

News Daily News

Infective Endocarditis in Opioid Users: Care Must Go Beyond the Heart

Caitlin E. Cox

February 26, 2024

News Daily News

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

L.A. McKeown

September 26, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2023

Shelley Wood

April 28, 2023

News Daily News

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

Todd Neale

December 28, 2022

News Daily News

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

Michael O'Riordan

October 01, 2021

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

L.A. McKeown

September 22, 2021

News Daily News

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Yael L. Maxwell

June 10, 2020

News Daily News

Opioid Use Does Not Impart Higher In-Hospital Mortality for Cardiac Surgery Patients

Caitlin E. Cox

December 06, 2018

News Daily News

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

Caitlin E. Cox

June 11, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

News Daily News

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

L.A. McKeown

July 14, 2017

News Daily News

More Conservative Antibiotic Prophylaxis for Infective Endocarditis Seems Safe, Appropriate

Todd Neale

April 28, 2017

News Daily News

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

Michael O'Riordan

December 27, 2015

News Daily News

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Michael O'Riordan

December 27, 2015

Advertisement

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

Infective Endocarditis in Opioid Users: Care Must Go Beyond the Heart

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

TCTMD’s Top 10 Most Popular Stories for April 2023

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Opioid Use Does Not Impart Higher In-Hospital Mortality for Cardiac Surgery Patients

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

More Conservative Antibiotic Prophylaxis for Infective Endocarditis Seems Safe, Appropriate

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content